Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)

NCT03983031 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder
Treatment Resistant Disorders

Interventions

DRUG: Rituximab

Sponsor

Region Örebro County

Collaborators

[object Object]